SCHEMBL6889219

SCHEMBL6889219

Cc1cc(C(=O)N[C@H]2CCCC[C@@H]2O)nc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 3/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50
▸ CNR1 P21554 5/20 0.49
▸ RXFP1 Q9HBX9 3/20 0.48
▸ USP2 O75604 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ ADAM17 P78536 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ TAS1R3 Q7RTX0 1/20 0.46
▸ TAS1R1 Q7RTX1 1/20 0.46
▸ TAS1R2 Q8TE23 1/20 0.46
▸ SCN9A Q15858 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13977569 0.86 CNR2 (0.49) CNR2RAB9ACNR1RXFP1SCN9A
SCHEMBL2269430 0.86 CNR2 (0.51) CNR2RAB9ACNR1RXFP1KDM4E
SCHEMBL2224924 0.86 CNR2 (0.51) CNR2RAB9ACNR1RXFP1KDM4E
SCHEMBL2224921 0.86 CNR2 (0.51) CNR2RAB9ACNR1RXFP1KDM4E
SCHEMBL2222196 0.86 CNR2 (0.51) CNR2RAB9ACNR1RXFP1KDM4E
SCHEMBL12802717 0.82 CHRM1 (0.57) ADAM17
SCHEMBL2223726 0.81 CHRM1 (0.54) CNR2CNR1ADAM17
SCHEMBL12802892 0.81 CHRM1 (0.53) ADAM17
SCHEMBL12803280 0.80 CNR2 (0.43) CNR2RAB9ACNR1SCN9A
SCHEMBL12803247 0.80 GABRA5 (0.47) CNR2ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2512243-B1 QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME (US) 2016-04-06 — — EP disclosed
WO-2011084368-A1 QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2011-07-14 — — WO disclosed
Send feedback